MoneyWorks4Me

Biocon informs about press release

21 May 2024 Evaluate

Biocon has informed that it enclosed the press release titled ‘Biocon Biologics’ Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili. Enters US Ophthalmology Market’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..